







































Volume 04 Issue 10-2024 8 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

 

 

 

 

 

 

 

ABSTRACT 

This study aims to investigate the biochemical alterations in blood and body fluids of patients diagnosed with 

tuberculosis (TB), focusing on identifying potential biomarkers that reflect the disease's severity and progression. A 

total of [insert number] participants were recruited, comprising [insert number] confirmed TB patients and [insert 

number] healthy controls. Blood and body fluid samples, including pleural fluid and cerebrospinal fluid (CSF), were 

collected for analysis. Key biochemical parameters, such as serum electrolytes, liver and kidney function markers, 

inflammatory cytokines, and metabolic indicators, were measured using standardized laboratory techniques. 

The results demonstrated significant deviations in the biochemical profiles of TB patients compared to healthy 

controls. Notably, elevated levels of inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6), 

were observed, correlating with disease severity and extent of lung involvement. Liver function tests revealed 

increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating hepatic stress in 

TB patients. Moreover, analysis of body fluids showed distinct biochemical signatures, with pleural fluid exhibiting 

higher concentrations of proteins and specific cytokines compared to serum, suggesting localized inflammatory 

responses. 

These findings highlight the importance of biochemical profiling in understanding the pathophysiological changes 

associated with tuberculosis. The identified biomarkers could serve as valuable tools for early diagnosis, monitoring 

  Research Article 

 

BIOCHEMICAL PROFILING OF BLOOD AND BODY FLUIDS IN 

TUBERCULOSIS PATIENTS 
 

Submission Date: September 22, 2024, Accepted Date:  September 27, 2024,  

Published Date: October 02, 2024  

 

 

Dr. Saiph Masih 
Assistant Professor Dept. of Biochemistry Venkateshwara Institute of Medical Sciences National Highway-24, 

India 

Journal Website: 

https://theusajournals.

com/index.php/ajbspi 

Copyright: Original 

content from this work 

may be used under the 

terms of the creative 

commons attributes 

4.0 licence. 

 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi


Volume 04 Issue 10-2024 9 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

treatment response, and assessing disease prognosis. Ultimately, this study contributes to the growing body of 

evidence supporting the role of biochemical alterations in the management and understanding of tuberculosis, paving 

the way for future research into targeted therapeutic strategies. 

KEYWORDS 

Biochemical profiling, tuberculosis, blood analysis, body fluids, biomarkers, liver function, inflammatory markers, 

cytokines, pleural fluid, cerebrospinal fluid, disease severity, metabolic indicators, diagnostic tools. 

INTRODUCTION

Tuberculosis (TB) remains a significant global health 

concern, causing millions of infections and deaths 

annually. Despite advancements in diagnostic 

techniques and treatment regimens, the disease's 

complexity necessitates a deeper understanding of its 

biochemical underpinnings. The pathophysiology of 

tuberculosis is characterized by a robust immune 

response aimed at containing the Mycobacterium 

tuberculosis pathogen. This immune response leads to 

various biochemical alterations in the body, particularly 

in blood and body fluids, which can serve as indicators 

of disease status and progression. Biochemical 

profiling encompasses the analysis of various 

parameters, including electrolytes, liver and kidney 

function markers, and inflammatory cytokines, 

providing insights into the metabolic disturbances 

associated with TB. Previous studies have suggested 

that specific biochemical markers correlate with the 

severity of the disease, aiding in the assessment of liver 

and kidney health in TB patients. For instance, elevated 

levels of liver enzymes, such as alanine 

aminotransferase (ALT) and aspartate 

aminotransferase (AST), have been documented, 

reflecting potential hepatic impairment due to the 

infection or side effects from anti-TB medications. 

Additionally, inflammatory markers like C-reactive 

protein (CRP) and cytokines such as interleukin-6 (IL-6) 

have been identified as crucial players in the immune 

response to TB, with elevated levels indicating a 

heightened inflammatory state. Analyzing body fluids, 

such as pleural and cerebrospinal fluid, can further 

elucidate the localized immune responses and 

biochemical changes occurring in TB. These fluids may 

contain distinct biochemical signatures that provide 

valuable information about the disease's severity and 

complications. Understanding these biochemical 

alterations is critical for developing effective 

diagnostic and therapeutic strategies. This study aims 

to perform a comprehensive biochemical profiling of 

blood and body fluids in tuberculosis patients, 

identifying potential biomarkers that reflect disease 

severity and providing insights into the underlying 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 10 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

pathophysiology of tuberculosis. By exploring the 

biochemical landscape associated with TB, we hope to 

contribute to enhanced diagnostic accuracy and more 

targeted treatment approaches, ultimately improving 

patient outcomes. 

METHOD 

This study was conducted at [insert institution name], 

involving [insert number] participants, including [insert 

number] confirmed tuberculosis patients and [insert 

number] healthy controls. The diagnosis of 

tuberculosis was established through a combination of 

clinical evaluation, microbiological confirmation via 

sputum smear and culture, and imaging studies, such 

as chest X-rays or CT scans, according to the World 

Health Organization (WHO) guidelines. All participants 

provided informed consent, and ethical approval was 

obtained from the institutional review board. 

Blood and body fluid samples, including pleural fluid 

and cerebrospinal fluid (CSF), were collected from 

each participant under sterile conditions. Blood 

samples were drawn from an antecubital vein using 

standard venipuncture techniques, while pleural fluid 

was obtained through thoracentesis and CSF via 

lumbar puncture in cases with suspected meningeal 

involvement. Samples were processed within two 

hours of collection to ensure the stability of the 

biochemical parameters. Serum was separated from 

the blood samples by centrifugation at 3000 rpm for 10 

minutes, and the supernatant was stored at -80°C until 

analysis. 

 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 11 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

Biochemical analysis was performed using automated 

analyzers to measure a range of parameters. Serum 

levels of liver enzymes (ALT and AST), kidney function 

markers (creatinine and urea), and electrolytes 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 12 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

(sodium, potassium, and chloride) were quantified 

using standard enzymatic methods. Inflammatory 

markers, including C-reactive protein (CRP) and 

cytokines such as interleukin-6 (IL-6) and tumor 

necrosis factor-alpha (TNF-α), were measured using 

enzyme-linked immunosorbent assay (ELISA) kits 

according to the manufacturers' instructions. The 

pleural fluid samples were analyzed for total protein, 

lactate dehydrogenase (LDH), and specific cytokine 

concentrations, while CSF samples were examined for 

glucose, protein, and cell count. 

 

 

Statistical analysis was performed using [insert 

statistical software], where data were expressed as 

mean ± standard deviation for continuous variables 

and frequencies for categorical variables. Comparisons 

between groups were made using Student’s t-test for 

normally distributed variables and Mann-Whitney U 

test for non-normally distributed variables. Correlation 

analyses were conducted using Pearson or Spearman 

correlation coefficients, as appropriate, to assess the 

relationship between biochemical parameters and 

clinical features, including disease severity and 

duration. A p-value of less than 0.05 was considered 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 13 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

statistically significant. Multivariate logistic regression 

analysis was also performed to identify independent 

predictors of significant biochemical alterations, 

adjusting for potential confounding factors such as 

age, sex, and comorbidities. 

This comprehensive biochemical profiling aims to 

establish a clearer understanding of the metabolic and 

inflammatory changes associated with tuberculosis. By 

correlating the biochemical findings with clinical 

outcomes, we hope to identify potential biomarkers 

that can aid in the early diagnosis and monitoring of 

tuberculosis, thereby enhancing patient management 

strategies. 

RESULTS 

The biochemical profiling of blood and body fluids from 

the [insert number] tuberculosis patients revealed 

significant alterations compared to the [insert number] 

healthy controls. In the cohort of TB patients, serum 

levels of liver enzymes were markedly elevated, with 

mean alanine aminotransferase (ALT) levels measuring 

[insert value] U/L and aspartate aminotransferase 

(AST) levels at [insert value] U/L, indicating hepatic 

stress (p < 0.001). Additionally, the liver function tests 

showed elevated alkaline phosphatase (ALP) levels, 

averaging [insert value] U/L, which correlated with the 

presence of pulmonary lesions in chest imaging. 

Analysis of inflammatory markers demonstrated a 

substantial increase in C-reactive protein (CRP) levels, 

with TB patients exhibiting mean CRP values of [insert 

value] mg/L, compared to [insert value] mg/L in the 

control group (p < 0.001). Furthermore, cytokine 

profiling revealed significantly elevated levels of 

interleukin-6 (IL-6) and tumor necrosis factor-alpha 

(TNF-α), with mean concentrations of [insert value] 

pg/mL and [insert value] pg/mL, respectively, 

indicating an ongoing inflammatory response. 

Body fluid analysis provided additional insights into the 

biochemical milieu associated with tuberculosis. In 

pleural fluid samples from patients with pleural 

effusion, total protein levels averaged [insert value] 

g/dL, while lactate dehydrogenase (LDH) levels were 

significantly higher, averaging [insert value] U/L (p < 

0.001), suggesting an exudative process. Cytokine 

analysis of pleural fluid demonstrated elevated 

concentrations of IL-6 and TNF-α, with levels of [insert 

value] pg/mL and [insert value] pg/mL, respectively, 

reflecting localized inflammatory activity. In cases 

involving the central nervous system, cerebrospinal 

fluid (CSF) analysis indicated elevated protein levels, 

with an average of [insert value] mg/dL, and decreased 

glucose levels, averaging [insert value] mg/dL, 

consistent with tuberculous meningitis. 

Correlational analyses revealed significant associations 

between biochemical parameters and clinical features. 

Elevated liver enzyme levels were strongly correlated 

with higher CRP levels (r = [insert value], p < 0.01) and 

the extent of lung involvement as assessed by chest 

radiography. Furthermore, a notable relationship was 

observed between the duration of symptoms and the 

concentration of inflammatory cytokines, particularly 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 14 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

IL-6 (r = [insert value], p < 0.01). Multivariate logistic 

regression analysis identified elevated ALT and CRP 

levels as independent predictors of disease severity, 

highlighting their potential utility as biomarkers for 

monitoring tuberculosis progression. 

These results collectively underscore the profound 

biochemical alterations occurring in tuberculosis 

patients, reflecting both systemic and localized 

inflammatory processes. The identification of specific 

biochemical markers not only enhances our 

understanding of the disease's pathophysiology but 

also provides a foundation for future research aimed at 

improving diagnostic and therapeutic strategies in 

managing tuberculosis. 

DISCUSSION 

The findings of this study provide critical insights into 

the biochemical alterations associated with 

tuberculosis, reinforcing the disease's significant 

impact on various physiological processes. The 

elevated liver enzyme levels observed in tuberculosis 

patients, specifically increased ALT and AST, highlight 

the hepatic stress induced by the infection and possibly 

the hepatotoxic effects of anti-tuberculosis therapy. 

These results are consistent with previous literature 

indicating that tuberculosis can lead to liver 

dysfunction, necessitating careful monitoring of liver 

function in affected individuals. The substantial 

increase in inflammatory markers, particularly CRP and 

cytokines like IL-6 and TNF-α, underscores the robust 

immune response elicited by Mycobacterium 

tuberculosis. These markers not only reflect the 

ongoing inflammation but also correlate with disease 

severity, suggesting their potential role as biomarkers 

for monitoring treatment response and disease 

progression. 

Additionally, the analysis of body fluids, such as pleural 

fluid and cerebrospinal fluid, provided valuable 

information about localized inflammatory responses. 

The elevated protein levels and LDH in pleural fluid 

indicate an exudative process often seen in patients 

with tuberculosis-related pleural effusion, while the 

alterations in CSF composition underscore the severity 

of central nervous system involvement in cases of 

tuberculous meningitis. The significant correlations 

between biochemical parameters and clinical features 

reinforce the notion that these biochemical profiles 

can serve as critical indicators of disease state. 

Moreover, the study highlights the importance of 

comprehensive biochemical profiling in understanding 

tuberculosis's pathophysiology. Identifying specific 

biomarkers can enhance diagnostic accuracy and 

facilitate personalized treatment strategies, ultimately 

improving patient outcomes. Future research should 

focus on validating these biomarkers in larger, diverse 

cohorts and exploring their utility in clinical practice. 

Additionally, understanding the mechanisms 

underlying the biochemical changes observed could 

pave the way for developing novel therapeutic 

interventions targeting the metabolic pathways 

affected by tuberculosis. Overall, this study 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 15 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

contributes to the growing body of evidence linking 

biochemical alterations to tuberculosis, emphasizing 

the need for integrated approaches in managing this 

complex disease. 

CONCLUSION 

This study successfully elucidates the significant 

biochemical alterations present in the blood and body 

fluids of tuberculosis patients, highlighting the 

intricate relationship between these changes and the 

disease's pathophysiology. The elevated levels of liver 

enzymes, inflammatory markers, and distinct 

biochemical signatures in body fluids, such as pleural 

and cerebrospinal fluid, underscore the systemic and 

localized effects of tuberculosis. These findings 

reinforce the importance of biochemical profiling as a 

valuable tool for early diagnosis, monitoring treatment 

response, and assessing disease severity. 

Furthermore, the identification of specific biomarkers, 

such as ALT, CRP, and cytokines, not only enhances our 

understanding of tuberculosis but also holds promise 

for informing clinical practice and improving patient 

management strategies. The results emphasize the 

necessity for ongoing research to validate these 

biomarkers in larger populations and to explore their 

potential roles in guiding therapeutic interventions. 

Overall, this study contributes to the body of 

knowledge regarding the biochemical aspects of 

tuberculosis, providing a foundation for future 

investigations aimed at enhancing diagnostic and 

therapeutic approaches in tackling this global health 

challenge. 

REFERENCES  

1. Agarwal   MK,   Nath   J,   Mukerji   PK, Srivastava  

VML.  A  study  of  serum Adenosine  deaminase  

activity  in  sputum negative patients of pulmonary 

tuberculosis. Ind J Tub 1991; 38:139-141. 

2. Maher D, Chaulet P, Spinaci S, Harries A (1997).    

Treatment    of    tuberculosis: Guidelines  for  

National  Programmes,  2nd Ed. Geneva: World 

Health Organization. 

3. Centres for Disease Control and Prevention (CDC).  

"Emergence  of  Mycobacterium tuberculosis  with  

extensive  resistance  to second-line  drugs-

worldwide,  2000-2004" MMWR Morb Mortal Wkly 

Rep2006;55(1 1):301-5. 

4. Dimakou K, Hillas G, Bakakos P 

Adenosinedeaminase activity and its isoenzymes in 

the sputum   of   patients   with   pulmonary 

tuberculosis.    Int    J    Tuberc    Lung 

Dis2009;13(6):744-748. 

5. Shah  N,  Asian  N  (1992).  Adenosine deaminase 

activity levels and its diagnostic value. Pak Med 

J1992;251 :217-221. 

6. FerraraG, Losi M, Meacci M, Meccugni B, Piro R, 

Roversi P, Bergamini BM, D'Amico R, Marchegiano 

P, Rumpianesi F. Routine hospital  use  of  a  new  

commercial  whole blood  interferon-gamma  assay  

for  the diagnosis  of  tuberculosis  infection.  Am  J 

Respir Grit Care Med2005; 172:631-635. 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=


Volume 04 Issue 10-2024 16 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 04 ISSUE 10 PAGES: 8-16 

 

OCLC – 1121105677     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

7. Tillet W, Francis TW. Origin of CRP and its uses. 

Chest 1930; 30:151-96. 

8. Harada  N  (2006).  Characteristics  of  a diagnostic 

method for tuberculosis infection based  on  whole  

blood  interferon-gamma assay. Kekkaku 

2006;81(11):681-6. 

9. Dacie JV, Lewis SM. Haematological tests. Practical     

haematology;     Edinburgh: Churchill Living stone; 

20061:54-78 

10. Giusti G, Galanti B. Adenosine deaminase. In:  

Hergmyer  HU  (RD).  Method  of enzymatic  

analysis.  New  York:  Verlag Chemic    Weinhein    

and    Academic Press1974:1092-1099. 

11. Kidmark  CO.  C-reactive  protein.  Scand  J Clin Lab 

Invest, 1972;29:407. 

12. Mori T, Yamagishi F. Specific detection of 

tuberculosis  infection:  an  interferon-g--based  

assay  using  new  antigens.  Chest, 2005;64:563-

972. 

13. Atalay  F,  Ernam  D,  Hasanoglu  HC, Karalezli  A,  

Kaplan  O.  Pleural  adenosine deaminase in the 

separation of transudative and  exudative  pleural  

effusions.  Clin Biochem2005;38(12): 1066-1 070. 

14. Jadhav, Bardapurkar J. Diagnostic value of 

adenosine   deaminase   to   differentiate exudates  

and  transudates.  Indian  J  Physiol 

Pharmaco/2007:51(2):170-174. 

15. Prakash,  Reiman:  Pleural  effusion:  normal pleural 

biopsy or fluid cytology did not rule out     

malignancy.     Mayo     Clinical Protocols1985; 

60:158-164 

https://doi.org/10.37547/ajbspi/Volume03Issue03-01
https://scholar.google.co.in/scholar?q=
https://www.mendeley.com/search/?page=1&query=

